MS
Mandeep Singh Kalra
About Mandeep Singh Kalra
Data last updated:
Mandeep Singh Kalra is an Additional Director at Systole Remedies Private Limited (since 2021), Director at Iris Prints Private Limited (since 2025) and Director at Flanca Life Sciences Private Limited (since 2022). The companies operate in Pharma. The largest current company by reported revenue is Systole Remedies Private Limited at ₹59.68 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Systole Remedies Private Limited U24230DL2005PTC191854 | Additional Director | 13 Jul 2021 | 2005 | ₹59.68 Cr (FY 2025) | Active |
 Iris Prints Private Limited U82920HP2025PTC012113 | Director | 27 Oct 2025 | 2025 | Active | |
| Flanca Life Sciences Private Limited U51909CH2022PTC044768 | Director | 30 Dec 2022 | 2022 | Active |
Board colleagues of Mandeep Singh Kalra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashok Thakur | 11324034 | Systole Remedies Private Limited | Director |
| Harsimran Singh Kalra | 08445853 | Systole Remedies Private Limited , Flanca Life Sciences Private Limited | Additional Director |
| Jitender Mohan Kalra | 08544394 | Systole Remedies Private Limited , Iris Prints Private Limited and 1 more | Additional Director |
| Pavneet Singh Kalra | 09239772 | Systole Remedies Private Limited , Flanca Life Sciences Private Limited | Additional Director |
| Pawan Kumar | 03336280 | Systole Remedies Private Limited | Person Incharge |
| Ravneet Singh | 08445822 | Systole Remedies Private Limited , Flanca Life Sciences Private Limited | Additional Director |
| Tanish Walia | 11356343 | Iris Prints Private Limited | Director |
| Vansh | 11356344 | Iris Prints Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mandeep Singh Kalra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mandeep Singh Kalra
Mandeep Singh Kalra currently holds 3 directorships: Systole Remedies Private Limited (Additional Director, since 13 Jul 2021, revenue ₹59.68 Cr (FY 2025)); Iris Prints Private Limited (Director, since 27 Oct 2025); Flanca Life Sciences Private Limited (Director, since 30 Dec 2022).
Mandeep Singh Kalra was first appointed on 13 Jul 2021 as Additional Director at Systole Remedies Private Limited. The most recent appointment on record is 27 Oct 2025 at Iris Prints Private Limited.
The current boards of Mandeep Singh Kalra's companies include Ashok Thakur (Systole Remedies Private Limited), Harsimran Singh Kalra (Systole Remedies Private Limited), Jitender Mohan Kalra (Systole Remedies Private Limited), Pavneet Singh Kalra (Systole Remedies Private Limited), Pawan Kumar (Systole Remedies Private Limited), Ravneet Singh (Systole Remedies Private Limited), among others.